HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

poly(aspartic acid-co-lactic acid)

structure in first source

Also Known As:

poly(AA-co-LA); poly(L-aspartic acid-co-lactic acid)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - poly(aspartic acid-co-lactic acid): 2
Macromolecular Substances: 97
- Polymers: 13051
  - Polyesters: 921
    - poly(aspartic acid-co-lactic acid): 2
Biomedical and Dental Materials
- Polymers: 13051
  - Polyesters: 921
    - poly(aspartic acid-co-lactic acid): 2
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - Polyesters: 921
        poly(aspartic acid-co-lactic acid): 2

Experts

1.	Chen, Chunying: 1 article (05/2012)
2.	Han, Siyuan: 1 article (05/2012)
3.	Jiao, Fang: 1 article (05/2012)
4.	Li, Wei: 1 article (05/2012)
5.	Liu, Yuexian: 1 article (05/2012)
6.	Nie, Xin: 1 article (05/2012)
7.	Wu, Yan: 1 article (05/2012)
8.	Xu, Qing: 1 article (05/2012)
9.	Zhao, Yuliang: 1 article (05/2012)
10.	Hara, Kaori: 1 article (12/2006)

Related Diseases

1.	Neoplasms (Cancer) 05/21/2012 - "Cellular viability assays indicate that the poly(AA-co-LA)/DPPE NPs did not induce cell death, whereas doxorubicin encapsulated NPs were cytotoxic to various types of tumor cells. " 05/21/2012 - "Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles."
2.	Neoplasm Metastasis (Metastasis) 12/01/2006 - "The effect of poly (aspartic acid-co-lactic acid) nanospheres on the lung metastasis of B16BL6 melanoma cells by intravenous administration."
3.	Melanoma (Melanoma, Malignant) 12/01/2006 - "The effect of poly (aspartic acid-co-lactic acid) nanospheres on the lung metastasis of B16BL6 melanoma cells by intravenous administration."

Related Drugs and Biologics

1.	Polymers
2.	Doxorubicin (Adriamycin)
3.	Antineoplastic Agents (Antineoplastics)
4.	tesmilifene (DPPE)

Related Therapies and Procedures

1.	Intravenous Administration
2.	Nanospheres